Route 92 Medical Raises $111 Million In Combined Series E And Debt Financing
12/14/21, 4:10 PM
Location
san mateoMoney raised
$111 million
Industry
financial services
Round Type
series e
Route 92 Medical, Inc., a private medical technology company dedicated to becoming the performance leader in stroke intervention, today announced that it has raised over $110 million in a combined Series E and debt financing. The capital raise consisted of a $56 million Series E financing round led by new investors InnovaHealth Partners and Norwest Venture Partners. The round was also supported by existing Route 92 Medical investors The Vertical Group and U.S. Venture Partners
Company Info
Location
san mateo, california, united states
Additional Info
The Route 92 Medical platform utilizes the Monopoint operating system including an 088 catheter delivered to the neurovasculature using the specialized Tenzing catheter. The firm focuses on a diversified portfolio of lead investment positions and collaborates closely with each management team. The firm invests in early to late-stage businesses across a wide range of sectors with a focus on consumer, enterprise, and healthcare.